Pared-Down Research Labs

Mar 16, 2020

As businesses and institutions hunker down to try to stem the spread of COVID-19, ScienceInsider reports labs are dialing back their research activities.

How much those activities are being curtailed varies by how severe the outbreak is in a particular area and is changing day by day, it notes. But researchers tell it that "none of the disruptions to their work compare to the human toll of the pandemic."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

P.1 Re-infection Concerns

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

Aiming for May

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

NIH Program to Address Structural Racism

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

PNAS Papers on Myelopathy GWAS in Japan, Hypertrophic Cardiomyopathy, MRSA Methylation

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.

Featured White Papers

From Data to Diagnosis: Delivering Results on a National Scale with Genomics England

Prevalence of Hereditary Cancer and Benefits of Multi-Gene Panel Testing

Analytical Verification of the CarrierSeq ECS Kit for the Ion GeneStudio S5 System

In-depth Quantification of Cell and Gene Therapy DNA Integrations Enabled with Single-cell Sequencing

Mar

16

Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community.

Mar

23

Featured Webinar

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

Menu